Route of Administration Segment Analysis: Oral (Largest Segment) vs Injectable (Fastest-Growing Segment)

The oral segment dominated the dementia treatment market in 2026, accounting for a 57.02% share, supported by the convenience, familiarity, and established use of orally administered therapies in long-term dementia management. Oral medications are generally easier for caregivers to administer and can be incorporated into routine treatment regimens, making them well suited to the ongoing nature of dementia care. Their established clinical use and accessibility through conventional healthcare channels further reinforce demand. In addition, the growing emphasis on maintaining treatment continuity and supporting home-based care contributes to the continued prominence of oral administration.

Injectable therapies represent the fastest-growing route of administration, driven by interest in treatment approaches that can address challenges associated with daily medication adherence and caregiver burden. Injectable administration can offer advantages in treatment management where consistent dosing is important, particularly for patients who experience difficulties with oral medication use. Continued development of longer-acting and specialized therapeutic approaches is also increasing interest in injectable options. As dementia care increasingly focuses on improving treatment adherence and individualized patient management, injectable therapies are gaining greater relevance.

Distribution Channel Segment Analysis: Hospital Pharmacy (Largest Segment) vs Online Pharmacy (Fastest-Growing Segment)

Holding the largest share of the dementia treatment market in 2026, the hospital pharmacy segment accounted for 62.37% of the market, reflecting the central role of hospitals in diagnosis, treatment initiation, medication management, and ongoing monitoring of dementia patients. Hospital pharmacies provide direct coordination between physicians, pharmacists, caregivers, and patients, supporting appropriate dispensing and counseling for complex treatment regimens. Their integration with clinical care is particularly valuable when treatment requires prescription oversight or adjustments based on patient response. Established hospital infrastructure and the continued reliance on specialist-led dementia management further strengthen this channel.

Online pharmacies are the fastest-growing distribution channel, benefiting from increasing demand for convenient medication access and the expansion of digitally enabled healthcare services. Home delivery can simplify prescription fulfillment for patients and caregivers who may face mobility or transportation challenges, particularly when treatment requires ongoing medication replenishment. Digital ordering also provides greater convenience and can support continuity of care when combined with electronic prescriptions and remote healthcare interactions. Growing consumer familiarity with online pharmaceutical purchasing is consequently creating additional momentum for this segment.